# VR1 Corp: Form D filings

VR1 Corp, a pharmaceuticals company in New York, NY, filed 6 Form D notices with the SEC between 2012 and 2014. The latest, on September 16, 2014, reports $900,279 sold of a $930,290 offering to 7 investors.

Find out what VR1 Corp does, who founded it and who invested, beyond what the filing says. $10 of credit on sign-up, no card.

- [Watch for new raises](https://specstream.ai/workspace/ask?q=Tell%20me%20when%20VR1%20Corp%20files%20a%20new%20Form%20D%20or%20reports%20more%20money%20sold%2C%20with%20the%20filing&src=data-formd&kind=alert&entity=VR1%20Corp&page=%2Fdata%2Fform-d%2Fcompany%2Fvr1-corp-1561045)
- [Get founders and investors](https://specstream.ai/workspace/ask?q=For%20VR1%20Corp%2C%20find%20what%20the%20company%20does%2C%20its%20website%2C%20the%20founders%20and%20executives%20with%20their%20LinkedIn%20and%20work%20email%2C%20its%20investors%20and%20every%20funding%20round%20with%20the%20amounts%2C%20its%20headcount%20and%20any%20reported%20valuation&src=data-formd&kind=record&entity=VR1%20Corp&page=%2Fdata%2Fform-d%2Fcompany%2Fvr1-corp-1561045)

## The full lists

This record is a row of these lists. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (company, CIK, street, city, state, ZIP and 4 more), which open on your screen as soon as the payment clears and come by email.

- [Form D filings in New York](https://specstream.ai/data/form-d/state/new-york): 4,357 rows, by operating companies, filed since November 1, 2024, $123.57, or the new rows each week for $19 a month. Buy: https://specstream.ai/data/form-d/state/new-york
- [Form D filings in Pharmaceuticals](https://specstream.ai/data/form-d/industry/pharmaceuticals): 346 rows, by operating companies, filed since November 1, 2024, $17.30, or the new rows each week for $19 a month. Buy: https://specstream.ai/data/form-d/industry/pharmaceuticals

SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.

## Company details from the filing

- Address: 68 EAST 131ST STREET, SUITE 307, New York, NY, 10037
- Phone: (212) 368-2500
- Industry: Pharmaceuticals
- Entity type: Corporation
- Incorporated in: Delaware
- Year incorporated: 2012
- Revenue range: Decline to Disclose
- Exemptions claimed: Rule 506(b)
- SEC identifier (CIK): 1561045

## Form D filings

| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
| --- | --- | --- | --- | --- | --- | --- | --- |
| Sep 16, 2014 | New notice | $930,290 | $900,279 | $30,011 | 7 | Aug 19, 2014 | [sec.gov](https://www.sec.gov/Archives/edgar/data/1561045/000156104514000002/0001561045-14-000002-index.htm) |
| May 13, 2014 | Amendment | $335,000 | $335,000 | $0 | 10 | Oct 18, 2013 | [sec.gov](https://www.sec.gov/Archives/edgar/data/1561045/000156104514000001/0001561045-14-000001-index.htm) |
| Dec 19, 2013 | Amendment | $150,000 | $150,000 | $0 | 7 | Oct 18, 2013 | [sec.gov](https://www.sec.gov/Archives/edgar/data/1561045/000156104513000004/0001561045-13-000004-index.htm) |
| Oct 28, 2013 | New notice | $63,000 | $63,000 | $0 | 3 | Oct 18, 2013 | [sec.gov](https://www.sec.gov/Archives/edgar/data/1561045/000156104513000002/0001561045-13-000002-index.htm) |
| Jul 1, 2013 | New notice | $530,000 | $530,000 | $0 | 6 | Jun 14, 2013 | [sec.gov](https://www.sec.gov/Archives/edgar/data/1561045/000156104513000001/0001561045-13-000001-index.htm) |
| Nov 7, 2012 | New notice | $624,000 | $624,000 | $0 | 6 | Nov 6, 2012 | [sec.gov](https://www.sec.gov/Archives/edgar/data/1561045/000156104512000001/0001561045-12-000001-index.htm) |

## Executive officers and directors named in the filing

| Name | Role | Note in the filing |
| --- | --- | --- |
| Anjan Chatterjee | Executive Officer, Director |  |
| Michele Harris | Executive Officer, Director |  |

## Other pharmaceuticals companies in New York that filed recently

- [NBO Pharma Inc.](https://specstream.ai/data/form-d/company/nbo-pharma-inc-2103906) $238,000 · Nov 9, 2026
- [Pierrepont Therapeutics, Inc.](https://specstream.ai/data/form-d/company/pierrepont-therapeutics-inc-2019360) $2.4 million · Sep 22, 2026

[Every Form D from the week of Sep 15, 2014](https://specstream.ai/data/form-d/week/2014-09-15) · [All recent filings in New York](https://specstream.ai/data/form-d/state/new-york) · [All recent Pharmaceuticals filings](https://specstream.ai/data/form-d/industry/pharmaceuticals)

Read from SEC EDGAR. Amount sold is what VR1 Corp reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under [CC BY 4.0](https://creativecommons.org/licenses/by/4.0/).